The observation that MCF7 breast cancer cells, in contrast to nontumorigenic MCF10A cells, display CYP4Z1 on their surface might indicate its usefulness in breast cancer immunotherapy [24]. The gene discussed is CYP4Z1; the disease is breast carcinoma.